Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 21, 2017 – The FDA announced the approval of La Jolla Pharmaceutical's Giapreza (angiotensin) to increase blood pressure (BP) in adults with septic shock or other distributive shock.
Return to publications